Vaccination Response Following Administration of Ixekizumab to Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 08 Jan 2017
At a glance
- Drugs Ixekizumab (Primary) ; DTaP vaccine; Pneumococcal vaccine
- Indications Plaque psoriasis; Psoriatic arthritis; Rheumatoid arthritis
- Focus Pharmacodynamics
- Sponsors Eli Lilly
- 17 Jan 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 03 Nov 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 19 Oct 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.